国产欧美性爱视频_一级黄色大香蕉_中文无码影视在线观看_黄色影院在线观看_亚洲国产综合专区_未成满18禁片无遮挡观看_成人剧情av麻豆映画国产_一本大道AV网站

EN
Investor Relations
Why Invest in CanSinoBIO
Bio-tech To Bio-pharma
  • ? From a biotechnology company to a biopharmaceutical company
  • ? Continuous investment in R&D, aligning with promising progress of core pipelines
  • ? BD Opportunities: licensing in & out, M&As and overseas partnership in pipelines
World Class R&D
  • ? Senior scientists and management team from leading global biopharmaceutical companies
  • ? Mature technology platforms with patents awarded & articles published in world-leading medical journals The Lancet, Nature etc.
  • ? Competitive advantages in mRNA technology platform and process of CMC associated with the mRNA platform is streamlined
International Manufacturing Standard
  • ? Core technical experts with in-depth understanding of international production standards and requirements
  • ? Design, construction & operation of production facilities meets international standards
Growing Commercialization Capability
  • ? Well-oiled commercialization engine with systematic management approach of a multi-national company
  • ? Unique Direct Sales and Sales Agency Model for growing market penetration, with commercial access to 31 provinces in China
  • ? Multiple strategic partnerships established for overseas market with considerable potential
Stock Information
H ShareCanSinoBIO（06185）
33.460
Data synchronization time 2026-03-13 16:08:20
More
A ShareCanSinoBIO（688185）
69.990
Data synchronization time 2026-03-13 15:00:01
More
Information Disclosure
Sustainability
IR Contact
To provide innovative, high-quality and affordable vaccine
Address:
401-420, 4th Floor, Biomedical Park, 185 South Avenue, TEDA West District, Tianjin, PRC
Hong Kong:
Room 1901, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay Hong Kong
Tel:
022-58213766
Email:
ir@www.lc348.cn